Control of Macrophage Activation and Function by PPARs

被引:430
作者
Chawla, Ajay [1 ,2 ]
机构
[1] Stanford Univ, Sch Med, Dept Med, Div Endocrinol Metab & Gerontol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Grad Program Immunol, Stanford, CA 94305 USA
关键词
inflammation; insulin resistance; atherosclerosis; diabetes; PPARs; alternatively activated macrophages; NITRIC-OXIDE SYNTHASE-2; ALTERNATIVE ACTIVATION; APOPTOTIC CELLS; FATTY-ACIDS; NEGATIVE REGULATOR; NUCLEAR RECEPTORS; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; INSULIN SENSITIVITY; INTERFERON-GAMMA;
D O I
10.1161/CIRCRESAHA.110.216523
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Macrophages, a key component of the innate defense against pathogens, participate in the initiation and resolution of inflammation, and in the maintenance of tissues. These diverse and at times antithetical functions of macrophages are executed via distinct activation states, ranging from classical to alternative to deactivation. Because the dysregulation of macrophage activation is pathogenically linked to various metabolic, inflammatory and immune disorders, regulatory proteins controlling macrophage activation have emerged as important new therapeutic targets. Here, the mechanisms by which peroxisome proliferator-activated receptors (PPARs) transcriptionally regulate macrophage activation in health and disease states, including obesity, insulin resistance and cardiovascular disease, are reviewed. (Circ Res. 2010;106:1559-1569.)
引用
收藏
页码:1559 / 1569
页数:11
相关论文
共 113 条
[1]   Apoptotic Cells Promote Their Own Clearance and Immune Tolerance through Activation of the Nuclear Receptor LXR [J].
A-Gonzalez, Noelia ;
Bensinger, Steven J. ;
Hong, Cynthia ;
Beceiro, Susana ;
Bradley, Michelle N. ;
Zelcer, Noam ;
Deniz, Jose ;
Ramirez, Cristina ;
Diaz, Mercedes ;
Gallardo, German ;
Ruiz de Galarreta, Carlos ;
Salazar, Jon ;
Lopez, Felix ;
Edwards, Peter ;
Parks, John ;
Andujar, Miguel ;
Tontonoz, Peter ;
Castrillo, Antonio .
IMMUNITY, 2009, 31 (02) :245-258
[2]  
ABRAMSON SL, 1990, J IMMUNOL, V144, P625
[3]   Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation [J].
Ali, AA ;
Weinstein, RS ;
Stewart, SA ;
Parfitt, AM ;
Manolagas, SC ;
Jilka, RL .
ENDOCRINOLOGY, 2005, 146 (03) :1226-1235
[4]   Conditional knockout of macrophage PPARγ increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice [J].
Babaev, VR ;
Yancey, PG ;
Ryzhov, SV ;
Kon, V ;
Breyer, MD ;
Magnuson, MA ;
Fazio, S ;
Linton, MF .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (08) :1647-1653
[5]   Genetic Manipulations of PPARs: Effects on Obesity and Metabolic Disease [J].
Barak, Yaacov ;
Kim, Suyeon .
PPAR RESEARCH, 2007, 2007
[6]   A nuclear receptor atlas: Macrophage activation [J].
Barish, GD ;
Downes, M ;
Alaynick, WA ;
Yu, RT ;
Ocampo, CB ;
Bookout, AL ;
Mangelsdorf, DJ ;
Evans, RM .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (10) :2466-2477
[7]   PPARδ:: a dagger in the heart of the metabolic syndrome [J].
Barish, GD ;
Narkar, VA ;
Evans, RM .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) :590-597
[8]   Integration of metabolism and inflammation by lipid-activated nuclear receptors [J].
Bensinger, Steven J. ;
Tontonoz, Peter .
NATURE, 2008, 454 (7203) :470-477
[9]   PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties [J].
Bouhlel, M. Amine ;
Derudas, Bruno ;
Rigamonti, Elena ;
Dievart, Rebecca ;
Brozek, John ;
Haulon, Stephan ;
Zawadzki, Christophe ;
Jude, Brigitte ;
Torpier, Gerard ;
Marx, Nikolaus ;
Staels, Bart ;
Chinetti-Gbaguidi, Giulia .
CELL METABOLISM, 2007, 6 (02) :137-143
[10]  
CAO H, 1989, J IMMUNOL, V143, P3524